Living with and beyond cancer with comorbid illness: a qualitative systematic review and evidence synthesis.


Journal

Journal of cancer survivorship : research and practice
ISSN: 1932-2267
Titre abrégé: J Cancer Surviv
Pays: United States
ID NLM: 101307557

Informations de publication

Date de publication:
02 2019
Historique:
received: 24 10 2018
accepted: 11 01 2019
pubmed: 28 1 2019
medline: 11 2 2020
entrez: 28 1 2019
Statut: ppublish

Résumé

To identify the qualitative evidence on the experience of cancer and comorbid illness from the perspective of patients, carers and health care professionals to identify psycho-social support needs, experience of health care, and to highlight areas where more research is needed. A qualitative systematic review following PRISMA guidance. Relevant research databases were searched using an exhaustive list of search terms. Two reviewers independently screened titles and abstracts and discussed variations. Included articles were subject to quality appraisal before data extraction of article characteristics and findings. Thomas and Harden's thematic synthesis of extracted findings was undertaken. Thirty-one articles were included in the review, covering a range of cancer types and comorbid conditions; with varying time since cancer diagnosis and apparent severity of disease for both cancer and other conditions. The majority of studies were published after 2010 and in high income countries. Few studies focused exclusively on the experience of living with comorbid conditions alongside cancer; such that evidence was limited. Key themes identified included the interaction between cancer and comorbid conditions, symptom experience, illness identities and ageing, self-management and the role of primary and secondary care. In addition to a better understanding of the complex experience of cancer and comorbidity, the review will combine with research prioritisation work with consumers to inform an interview study with the defined patient group. Expanding this evidence base will help to illuminate developing models of cancer patient-centred follow-up care for the large proportion of patients with comorbid conditions.

Identifiants

pubmed: 30685822
doi: 10.1007/s11764-019-0734-z
pii: 10.1007/s11764-019-0734-z
pmc: PMC6394454
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

148-159

Subventions

Organisme : Chief Scientist Office
ID : PDF/15/06
Pays : United Kingdom

Références

Diabetes Educ. 2012 Nov-Dec;38(6):779-90
pubmed: 22983823
Lancet. 2012 Jul 7;380(9836):37-43
pubmed: 22579043
Cult Med Psychiatry. 2012 Dec;36(4):584-600
pubmed: 23054293
BMJ Open. 2017 May 9;7(5):e013383
pubmed: 28487455
Chronic Illn. 2014 Jun;10(2):81-92
pubmed: 23892774
Cancer Nurs. 2009 Sep-Oct;32(5):359-69
pubmed: 19661799
J Cancer Surviv. 2015 Dec;9(4):641-9
pubmed: 25716644
Palliat Support Care. 2013 Apr;11(2):101-9
pubmed: 23089464
Eur J Oncol Nurs. 2013 Jun;17(3):311-6
pubmed: 22947216
J Ment Health. 2015 Dec;24(6):351-6
pubmed: 25564890
Br J Gen Pract. 2014 Jul;64(624):e440-7
pubmed: 24982497
J Psychosoc Oncol. 2013;31(1):65-82
pubmed: 23311972
Br J Gen Pract. 2015 Nov;65(640):e761-8
pubmed: 26500324
Psychooncology. 2016 Sep;25(9):1079-84
pubmed: 27423160
Fam Pract. 2011 Dec;28(6):647-54
pubmed: 21693683
BMJ Open. 2014 May 22;4(5):e005186
pubmed: 24852301
J Cancer Surviv. 2015 Jun;9(2):239-51
pubmed: 25319681
BMC Health Serv Res. 2014 Jun 26;14:281
pubmed: 24969758
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Br J Gen Pract. 2011 Nov;61(592):e763-5
pubmed: 22054341
J Clin Oncol. 2011 May 20;29(15):2091-8
pubmed: 21519023
Lancet Oncol. 2017 Jan;18(1):e11-e18
pubmed: 28049573
J Adv Nurs. 2009 Apr;65(4):706-23
pubmed: 19278415
Br J Cancer. 2012 Sep 25;107(7):1195-202
pubmed: 22892390
Br J Gen Pract. 2009 Jul;59(564):e248-59
pubmed: 19566991
Can Oncol Nurs J. 2014 Summer;24(3):166-8, 174-7
pubmed: 25189054
J Geriatr Oncol. 2016 Jul;7(4):249-57
pubmed: 26725537
Am J Manag Care. 2011 Apr;17(4):259-65
pubmed: 21615196
Lancet Oncol. 2017 Jan;18(1):e30-e38
pubmed: 28049575
Br J Gen Pract. 2009 Jul;59(564):e234-47
pubmed: 19566990
Ageing Soc. 2013 Feb 1;33(2):342-360
pubmed: 24976658
Health (London). 2008 Jul;12(3):389-411
pubmed: 18579634
BMC Fam Pract. 2013 Sep 08;14:133
pubmed: 24010523
Cancer Nurs. 2003 Apr;26(2):85-96
pubmed: 12660557
Oncol Nurs Forum. 2013 Jan;40(1):64-71
pubmed: 23269771
CA Cancer J Clin. 2016 Jul;66(4):337-50
pubmed: 26891458
Fam Pract. 2014 Apr;31(2):209-14
pubmed: 24465025
J Cancer Surviv. 2016 Dec;10(6):990-1011
pubmed: 27138994
Sociol Health Illn. 1982 Jul;4(2):167-82
pubmed: 10260456
BMC Med Res Methodol. 2008 Jul 10;8:45
pubmed: 18616818
J Gen Intern Med. 2009 Nov;24 Suppl 2:S459-66
pubmed: 19838851
BMJ Support Palliat Care. 2016 Mar;6(1):60-5
pubmed: 25023218
Br J Health Psychol. 2016 May;21(2):351-73
pubmed: 26689299
Am J Manag Care. 2008 Apr;14(4):213-24
pubmed: 18402514
Psychooncology. 2015 Sep;24(9):1036-42
pubmed: 25645068
Eur J Oncol Nurs. 2012 Feb;16(1):64-70
pubmed: 21486709
J Clin Oncol. 2005 Dec 1;23(34):8884-93
pubmed: 16314649
Support Care Cancer. 2012 Nov;20(11):2785-94
pubmed: 22354621
Cancer Nurs. 2012 Mar-Apr;35(2):83-8
pubmed: 21760488
J Adv Nurs. 2008 May;62(4):499-509
pubmed: 18373612
Lancet Oncol. 2017 Jan;18(1):e19-e29
pubmed: 28049574
BMJ. 2012 Sep 03;345:e5205
pubmed: 22945950
Br J Gen Pract. 2012 Apr;62(597):e297-307
pubmed: 22520918
Health (London). 2010 Mar;14(2):178-95
pubmed: 20164165
BMC Med Res Methodol. 2009 Aug 11;9:59
pubmed: 19671152
Chronic Illn. 2011 Mar;7(1):45-59
pubmed: 20974642
BMJ Open. 2013 Apr 10;3(4):
pubmed: 23578681
Oncologist. 2018 Apr;23(4):433-439
pubmed: 29242282
Support Care Cancer. 2010 Dec;18(12):1521-30
pubmed: 20967554
BMJ. 2012 Sep 07;345:e5915
pubmed: 22960377
Eur J Surg Oncol. 2015 Sep;41(9):1234-42
pubmed: 26108734
Integr Cancer Ther. 2015 May;14(3):240-8
pubmed: 25716349
Can Fam Physician. 2001 Oct;47:2009-12, 2015-6
pubmed: 11723595
J Aging Stud. 2016 Jan;36:17-25
pubmed: 26880601

Auteurs

Debbie Cavers (D)

Usher Institute, Medical School, University of Edinburgh, Teviot Place, Edinburgh, EH8 9AG, UK. Debbie.Cavers@ed.ac.uk.

Liset Habets (L)

Leiden University Medical Center, University of Leiden, Albinusdreef 2, 2333, Leiden, ZA, Netherlands.

Sarah Cunningham-Burley (S)

Medical and Family Sociology, Usher Institute, Medical School, University of Edinburgh, Teviot Place, Edinburgh, EH8 9AG, UK.

Eila Watson (E)

Supportive Cancer Care, Faculty of Health and Life Sciences, Oxford Brookes University, Jack Straws Lane, Marston, Oxford, OX3 0FL, UK.

Elspeth Banks (E)

, 1 Carnwath Lane, Carluke, South Lanarkshire, ML8 4QU, UK.

Christine Campbell (C)

Usher Institute, Medical School, University of Edinburgh, Teviot Place, Edinburgh, EH8 9AG, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH